Implications of product withdrawal on a post-approval pragmatic trial: The VOLUME study experience.

Kolitsopoulos, Francesca M; Gatto, Nicolle M; Sweetland, Kevin; Bracken, Michael B; Jackson, Neville

Kolitsopoulos, Francesca M; Gatto, Nicolle M; Sweetland, Kevin; Bracken, Michael B; Jackson, Neville.

Afiliação

Kolitsopoulos FM; Epidemiology, Worldwide Safety & Regulatory, Pfizer Inc, New York, NY, USA.
Gatto NM; Epidemiology, Worldwide Safety & Regulatory, Pfizer Inc, New York, NY, USA.
Sweetland K; Pfizer Global Research & Development, Groton, CT, USA.
Bracken MB; Yale University Schools of Public Health and Medicine, New Haven, CT, USA.
Jackson N; Pfizer Global Research & Development, Groton, CT, USA.

Contemp Clin Trials Commun ; 16: 100477, 2019 Dec.

Article em En | MEDLINE | ID: mdl-31799472

Palavras-chave

Closure; Commercial withdrawal; Large simple trial; Pragmatic; Product withdrawal

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Aspecto: Ethics Idioma: En Revista: Contemp Clin Trials Commun Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Holanda

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google